title: Acceptance and compliance with postpartum human papillomavirus vaccination.
abstract: OBJECTIVE
  Despite the efficacy of vaccines against human papillomavirus (HPV), vaccination rates remain low in many countries. We estimated the acceptability and satisfaction of HPV vaccination in postpartum women.
  
  
  METHODS
  Postpartum women aged 18-26 years were offered the quadrivalent HPV vaccine. Women were vaccinated during hospitalization after delivery, at the 6-week postpartum visit, and at a third dedicated vaccination visit. The primary outcome was completion of all three vaccinations. Secondary outcomes included the influence of knowledge and attitudes of HPV, decisional conflict, and satisfaction.
  
  
  RESULTS
  A total of 150 women were enrolled. Overall, seven (4.7%) women did not receive any doses of the vaccine, 62 (41.3%) received one dose, 35 (23.3%) received two doses, and 46 (30.7%) completed the series and received all three doses of the vaccine. Knowledge of HPV and HPV-related disease, attitudes about HPV, and decisional conflict were not associated with completion of the vaccine series (P>.05). The vaccine was well tolerated with few side effects. The majority of women reported a high degree of satisfaction with postpartum vaccination; 97.2% thought vaccination was worthwhile, 98.6% thought postpartum vaccination was convenient, and 99.3% were happy they participated. Furthermore, 50.4% of women reported that they would not have otherwise asked about vaccination. After vaccination, only 17.5% said they would have rather made a separate trip for vaccination.
  
  
  CONCLUSIONS
  A strategy of postpartum HPV vaccination is convenient and associated with a high degree of patient satisfaction.
  
  
  METHODS
  II.
authors.affiliation: Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, Mailman School of Public Health, and the Herbert Irving Comprehensive Cancer Center, New York, New York 10032, USA. jw2459@columbia.edu
authors.forename: Jason D
authors.initials: JD
authors.lastname: Wright
authors.forename: Shravya
authors.initials: S
authors.lastname: Govindappagari
authors.forename: Neha
authors.initials: N
authors.lastname: Pawar
authors.forename: Kirsten
authors.initials: K
authors.lastname: Cleary
authors.forename: William M
authors.initials: WM
authors.lastname: Burke
authors.forename: Patricia C
authors.initials: PC
authors.lastname: Devine
authors.forename: Yu-Shiang
authors.initials: YS
authors.lastname: Lu
authors.forename: Wei-Yann
authors.initials: WY
authors.lastname: Tsai
authors.forename: Sharyn N
authors.initials: SN
authors.lastname: Lewin
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Herzog
mesh_terms: D000293:Adolescent; D000328:Adult; D002755:Choice Behavior; D015331:Cohort Studies; D005260:Female; D007722:Health Knowledge, Attitudes, Practice; D006801:Humans; D007115:Immunization Schedule; D016015:Logistic Models; D015999:Multivariate Analysis; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage*; D010342:Patient Acceptance of Health Care / Q000523:psychology / Q000706:statistics & numerical data*; D010349:Patient Compliance / Q000523:psychology / Q000706:statistics & numerical data; D017060:Patient Satisfaction / Q000706:statistics & numerical data; D049590:Postpartum Period; D011795:Surveys and Questionnaires; D014611:Vaccination / Q000379:methods / Q000523:psychology* / Q000706:statistics & numerical data; D055815:Young Adult
chemical_list: D053918:Papillomavirus Vaccines